Diagnostic Approach to White Matter Bright Signals

Primary Diagnostic Consideration

Small vessel disease represents chronic microvascular ischemic changes affecting deep white matter and periventricular regions, typically in frontal and parietal lobes, and is the most common consideration in patients over 50 years old 1
The American College of Radiology suggests that lesions less than 0.6 cm, non-enhancing, and without restricted diffusion on DWI sequences are characteristic of small vessel disease 1
The absence of vascular risk factors makes small vessel disease less likely but does not exclude it, as it can occur in otherwise healthy individuals 1
Periventricular "caps" and lesions less than 3 mm in longest axis are considered normal variants and do not require further workup 1

Lesions less than 3 mm do not meet diagnostic criteria for multiple sclerosis, even if other features are present 1
Lesions 3 mm or larger with ovoid shape perpendicular to the corpus callosum suggest multiple sclerosis 1
A single lesion measuring 3 mm or larger requires evaluation of specific location and morphology 1
Multiple sclerosis diagnosis requires typical lesions in at least two characteristic regions, not just isolated frontal-parietal foci 1

Increased risk of stroke and all-cause mortality is observed in affected individuals, even without traditional vascular risk factors 1
The absence of T1 hypointensity suggests potentially reversible injury, which is prognostically favorable 1

For patients over 50 years, attribute findings to cerebral small vessel disease and implement aggressive vascular risk factor optimization, including blood pressure control, statin therapy, diabetes screening and management, and smoking cessation counseling 1
Monitor for cognitive decline with serial assessments using standardized cognitive testing 1
For patients under 50 years without vascular risk factors, obtain follow-up MRI in 3-6 months to assess for new lesions 1
The American College of Radiology recommends immediate further investigation for progressive neurological symptoms, lesions with mass effect, enhancement, or restricted diffusion 2